BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26820615)

  • 1. AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis.
    Caraceni P; Angeli P; Prati D; Bernardi M; ; Liumbruno GM; Bennardello F; Piccoli P; Velati C;
    Blood Transfus; 2016 Jan; 14(1):8-22. PubMed ID: 26820615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis.
    ;
    Dig Liver Dis; 2016 Jan; 48(1):4-15. PubMed ID: 26802734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical indications for the albumin use: still a controversial issue.
    Caraceni P; Domenicali M; Tovoli A; Napoli L; Ricci CS; Tufoni M; Bernardi M
    Eur J Intern Med; 2013 Dec; 24(8):721-8. PubMed ID: 23790570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: albumin for circulatory support in patients with cirrhosis.
    Ginès P; Guevara M; De Las Heras D; Arroyo V
    Aliment Pharmacol Ther; 2002 Dec; 16 Suppl 5():24-31. PubMed ID: 12423450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin in chronic liver disease: structure, functions and therapeutic implications.
    Spinella R; Sawhney R; Jalan R
    Hepatol Int; 2016 Jan; 10(1):124-32. PubMed ID: 26420218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of albumin in patients with decompensated cirrhosis: the case in favor.
    Maor Y
    Isr Med Assoc J; 2005 Feb; 7(2):115-8. PubMed ID: 15729966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin infusion in liver cirrhotic patients.
    Rena NM; Wibawa ID
    Acta Med Indones; 2010 Jul; 42(3):162-8. PubMed ID: 20724771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of albumin infusion in decompensated liver cirrhosis].
    Schmidt LE; Ring-Larsen H
    Ugeskr Laeger; 2002 Feb; 164(9):1196-202. PubMed ID: 11899505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human serum albumin, systemic inflammation, and cirrhosis.
    Arroyo V; García-Martinez R; Salvatella X
    J Hepatol; 2014 Aug; 61(2):396-407. PubMed ID: 24751830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure.
    Mirici-Cappa F; Caraceni P; Domenicali M; Gelonesi E; Benazzi B; Zaccherini G; Trevisani F; Puggioli C; Bernardi M
    World J Gastroenterol; 2011 Aug; 17(30):3479-86. PubMed ID: 21941414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of cirrhotic complications with human serum albumin].
    Henriksen JH; Ring-Larsen H
    Ugeskr Laeger; 2005 Jan; 167(4):414. PubMed ID: 15719571
    [No Abstract]   [Full Text] [Related]  

  • 13. AISF-SIMTI position paper on the appropriate use of albumin in patients with liver cirrhosis: a 2020 update.
    Caraceni P; Angeli P; Prati D; Bernardi M; Berti P; Bennardello F; Fiorin F; Piccoli P;
    Blood Transfus; 2021 Jan; 19(1):9-13. PubMed ID: 33370229
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis].
    Grange JD; Amiot X
    Gastroenterol Clin Biol; 2000 Mar; 24(3):378-9. PubMed ID: 10866518
    [No Abstract]   [Full Text] [Related]  

  • 15. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.
    Singh V; Kumar B; Nain CK; Singh B; Sharma N; Bhalla A; Sharma AK
    J Intern Med; 2006 Jul; 260(1):62-8. PubMed ID: 16789980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
    Hamdy H; ElBaz AA; Hassan A; Hassanin O
    J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
    Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
    Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: albumin in the treatment of liver diseases--new features of a classical treatment.
    Arroyo V
    Aliment Pharmacol Ther; 2002 Dec; 16 Suppl 5():1-5. PubMed ID: 12423447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyponatremia in cirrhosis.
    Sigal SH
    J Hosp Med; 2012 Apr; 7 Suppl 4():S14-7. PubMed ID: 22489081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [When should we give albumin in patients with cirrhosis?].
    Bochatay L; Elkrief L; Spahr L
    Rev Med Suisse; 2015 Sep; 11(484):1596, 1598-601. PubMed ID: 26502620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.